GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cann Group Ltd (OTCPK:CNGGF) » Definitions » Debt-to-Revenue

CNGGF (Cann Group) Debt-to-Revenue : 5.59 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Cann Group Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Cann Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $45.61 Mil. Cann Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.22 Mil. Cann Group's annualized Revenue for the quarter that ended in Dec. 2024 was $8.19 Mil. Cann Group's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 5.59.


Cann Group Debt-to-Revenue Historical Data

The historical data trend for Cann Group's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cann Group Debt-to-Revenue Chart

Cann Group Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Debt-to-Revenue
Get a 7-Day Free Trial 14.39 0.16 7.36 4.43 4.71

Cann Group Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 3.83 3.78 5.26 5.59

Competitive Comparison of Cann Group's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cann Group's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cann Group's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cann Group's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cann Group's Debt-to-Revenue falls into.


;
;

Cann Group Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Cann Group's Debt-to-Revenue for the fiscal year that ended in Jun. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(47.839 + 0.28) / 10.208
=4.71

Cann Group's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(45.606 + 0.22) / 8.192
=5.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2024) Revenue data.


Cann Group Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cann Group's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cann Group Business Description

Traded in Other Exchanges
Address
262-276 Lorimer Street, Ground Floor, Port Melbourne, VIC, AUS, 3207
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.

Cann Group Headlines

From GuruFocus

Cann Group Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Full Year 2023 Cann Group Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Full Year 2020 Cann Group Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd at Investor Update webinar Transcript

By GuruFocus Research 02-13-2024

Full Year 2019 Cann Group Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Cann Group Ltd Ordinary Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024